TAGLIAFICO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 26.021
AS - Asia 13.186
EU - Europa 13.085
SA - Sud America 1.878
AF - Africa 378
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 34
Totale 54.654
Nazione #
US - Stati Uniti d'America 25.546
SG - Singapore 3.914
GB - Regno Unito 3.809
CN - Cina 3.217
IT - Italia 2.749
HK - Hong Kong 1.909
VN - Vietnam 1.580
BR - Brasile 1.410
SE - Svezia 1.367
DE - Germania 1.149
FI - Finlandia 644
RU - Federazione Russa 644
FR - Francia 619
TR - Turchia 459
KR - Corea 424
UA - Ucraina 413
NL - Olanda 403
IN - India 365
ID - Indonesia 264
CA - Canada 262
IE - Irlanda 233
BG - Bulgaria 192
BD - Bangladesh 162
SI - Slovenia 157
AR - Argentina 151
IQ - Iraq 131
JP - Giappone 130
MX - Messico 128
PL - Polonia 113
ZA - Sudafrica 108
ES - Italia 92
PK - Pakistan 84
BE - Belgio 78
EC - Ecuador 77
CO - Colombia 71
CZ - Repubblica Ceca 66
AE - Emirati Arabi Uniti 64
AU - Australia 63
CL - Cile 59
MA - Marocco 56
AT - Austria 55
LT - Lituania 54
IR - Iran 53
MY - Malesia 49
KE - Kenya 48
SA - Arabia Saudita 42
EG - Egitto 39
UZ - Uzbekistan 39
TN - Tunisia 36
CH - Svizzera 34
VE - Venezuela 34
GR - Grecia 28
IL - Israele 28
PH - Filippine 28
TW - Taiwan 28
NP - Nepal 27
PY - Paraguay 26
RO - Romania 26
QA - Qatar 21
AZ - Azerbaigian 19
EU - Europa 19
PE - Perù 19
TH - Thailandia 19
DZ - Algeria 18
JO - Giordania 18
RS - Serbia 17
HU - Ungheria 16
PT - Portogallo 16
NO - Norvegia 15
UY - Uruguay 15
JM - Giamaica 14
KG - Kirghizistan 14
OM - Oman 14
BO - Bolivia 13
DK - Danimarca 13
MD - Moldavia 13
BH - Bahrain 12
AL - Albania 11
KZ - Kazakistan 11
PA - Panama 11
TT - Trinidad e Tobago 11
SN - Senegal 10
CR - Costa Rica 9
ET - Etiopia 9
GE - Georgia 9
NG - Nigeria 9
NZ - Nuova Zelanda 9
SY - Repubblica araba siriana 9
XK - ???statistics.table.value.countryCode.XK??? 9
BY - Bielorussia 8
DO - Repubblica Dominicana 8
HR - Croazia 8
KW - Kuwait 8
MK - Macedonia 8
NI - Nicaragua 7
PS - Palestinian Territory 7
BA - Bosnia-Erzegovina 6
EE - Estonia 6
GH - Ghana 6
LB - Libano 6
Totale 54.536
Città #
Southend 2.695
Ashburn 2.641
Singapore 2.463
Fairfield 2.401
Santa Clara 2.362
Hong Kong 1.851
Chandler 1.503
Woodbridge 1.458
San Jose 1.136
Houston 1.100
Seattle 865
Hefei 814
Ann Arbor 800
Nyköping 771
Wilmington 739
Cambridge 729
Beijing 687
Jacksonville 681
Dearborn 617
London 569
Chicago 482
Ho Chi Minh City 473
Los Angeles 468
Modena 467
Helsinki 442
Seoul 399
Council Bluffs 384
Hanoi 379
The Dalles 354
New York 331
Amsterdam 271
San Diego 267
Izmir 228
Dublin 224
Milan 222
Salt Lake City 202
Jakarta 199
Munich 194
Princeton 190
Sofia 189
Lauterbourg 169
Moscow 167
Shanghai 163
São Paulo 140
Eugene 137
Buffalo 134
Bologna 131
Dallas 122
Fremont 112
Tampa 108
Orem 105
Frankfurt am Main 103
Elk Grove Village 96
Bremen 94
Tokyo 94
Rome 91
Da Nang 77
Falls Church 76
Des Moines 70
Toronto 70
Warsaw 70
Redwood City 69
Brussels 66
Turku 65
Denver 64
Montreal 62
Reggio Emilia 62
Johannesburg 60
Phoenix 59
Columbus 58
Haiphong 58
Parma 58
Nuremberg 56
Chennai 55
Dong Ket 53
Atlanta 52
Boardman 52
Baghdad 50
Guangzhou 49
Sterling 46
Brooklyn 44
Mexico City 44
Rio de Janeiro 43
Lancaster 42
Poplar 41
Brno 40
Biên Hòa 39
Stockholm 39
Manchester 38
Ottawa 38
Brasília 36
San Francisco 36
Nairobi 35
Miami 34
Belo Horizonte 33
Falkenstein 33
Florence 33
Sant'Ilario d'Enza 33
Verona 33
Norwalk 31
Totale 37.415
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 556
A Next Generation Sequencing amplicon-based strategy to explore Inherited Retinal Degeneration complexity 521
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 500
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 455
Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress 442
The barley Frost resistance-H2 locus 441
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 424
MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation 423
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 419
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 410
NF-YA splice variants have different roles on muscle differentiation 406
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 406
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Hybrid Posters 399
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 399
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells 393
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 393
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 390
A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response 381
Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic microenvironment 380
ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences. 379
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 370
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 366
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 364
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 361
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 360
Mutations and prognosis in primary myelofibrosis 359
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 359
Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells 358
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 358
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 358
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 355
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 354
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 353
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 353
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial 352
Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy 351
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 347
No Identical ‘‘Mesenchymal Stem Cells’’ at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels 345
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 344
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 343
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 343
Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells 342
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 342
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 342
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group 338
From gating to computational flow cytometry: Exploiting artificial intelligence for MRD diagnostics 336
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 336
Gene expression in grapevine cultivars in response to BOIS NOIR phytoplasma infection 335
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 330
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 329
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 329
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 328
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 326
Hereditary pancreatic cancer: A retrospective single-center study of 5143 Italian families with history of BRCA-related malignancies 324
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 323
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 323
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 316
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 315
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 315
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 311
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 311
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 311
Regulation of ob gene expression: evidence for epinephrine-induced suppression in human obesity 304
Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: focus on DNA repair genes 302
Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial). 298
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 298
Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy 298
Polarization dictates iron handling by inflammatory and alternatively activated macrophages 297
TGFβ/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts 296
Usefulness and limitations of comprehensive characterization of mRNA splicing profiles in the definition of the clinical relevance of BRCA1/2 variants of uncertain significance 294
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 293
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 292
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation. 291
HGM 2010 Programme / Abstract 290
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 289
Allele specific CRISPR/Cas9 editing of dominant Epidermolysis Bullosa Simplex in human epidermal stem cells 287
Regulatory Mrna/Microrna Networks in CD34+ Cells From Primary Myelofibrosis 287
Differentiated Neuroprogenitor Cells Incubated with Human or Canine Adenovirus, or Lentiviral Vectors Have Distinct Transcriptome Profiles 287
DIAGNOSI MOLECOLARE DELLE IPERTRIGLICERIDEMIE PRIMITIVE ATTRAVERSO “NGS” (NEXT GENERATION SEQUENCING) 285
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 285
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 285
Identification of new p63 targets in human keratinocytes 282
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 282
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-miR-299-5p in CD34+ progenitor cells commitment 280
Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation 279
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 275
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 274
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 273
Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy 270
Transcriptional changes in grapevine in response to Bois Noir infection 269
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 266
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 265
Nfix Regulates Fetal-Specific Transcription in Developing Skeletal Muscle 263
Gene expression profiling in MDS and AML: potential and future avenues 263
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 262
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 259
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 258
FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities 257
All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells 257
Bile acid structure and regulation of biliary protein secretion and composition in man 255
Totale 33.479
Categoria #
all - tutte 204.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 204.476


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021695 0 0 0 0 0 0 0 0 0 0 356 339
2021/20224.007 264 391 383 237 179 251 206 178 394 339 665 520
2022/20234.772 544 592 498 414 515 581 112 429 649 51 193 194
2023/20243.123 117 148 219 258 484 284 387 414 91 124 201 396
2024/202510.119 307 136 226 613 1.848 1.454 836 624 1.189 454 1.141 1.291
2025/202618.057 1.384 832 1.451 2.268 3.375 1.310 2.447 920 1.834 1.878 358 0
Totale 55.060